Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer

OBJECTIVE: The Immunoscore method has proved fruitful for predicting prognosis in patients with colon cancer. However, there is still room for improvement in this scoring method to achieve further advances in its clinical translation. This study aimed to develop and validate a modified Immunoscore (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ke, Wu, Xiaomei, Li, Zhenhui, Wang, Yingyi, Xu, Zeyan, Li, Yajun, Wu, Lin, Yao, Su, Huang, Yanqi, Liang, Changhong, Liu, Zaiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286894/
https://www.ncbi.nlm.nih.gov/pubmed/34321834
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286894/
https://www.ncbi.nlm.nih.gov/pubmed/34321834
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.09

Ejemplares similares